#Bioanalysis
Explore real-world examples of Evosep in bioanalysis through application notes, peer-reviewed research, scientific highlights, and on-demand content.

See the approach in action: www.evosep.com/bioanalysis/...
November 19, 2026 at 1:00 PM
High-end analytics alone don’t accelerate a drug discovery program.

ICP-MS detects metals at parts-per-trillion. What moves metal-labeled programs forward is a biodistribution finding that skips the report and reaches bioanalysts, PK scientists, biologists and chemists.

Read the article ↓
ICP-MS in Drug Discovery: Precision Bioanalysis for Metal-Labeled Therapeutics | IRBM
IRBM's integrated ICP-MS platform delivers ppt-level sensitivity for metal-labeled compound bioanalysis supporting biodistribution, cell uptake, and theranostic drug discovery within a single, connected DMPK team.
www.irbm.com
November 20, 2026 at 3:30 PM
Bioanalysis Leadership Opportunities - Ithaca, New York, United States of America Job educativ.net/jobs/job/68502...
November 16, 2026 at 9:57 PM
#$CRL will acquire Frontage’s bioanalysis and DMPK businesses in Exton, PA for approximately $470 million in cash. notreload.xyz/xy/crl-buys-...
Charles River Buys Frontage Bioanalysis for $470M
The acquisition adds Frontage’s clinical bioanalysis expertise and strengthens Charles River’s drug development offering.
notreload.xyz
November 9, 2026 at 11:30 AM
Meet Evosep at EBF 2026!

Come and talk to our team to discover how standardized and scalable LC-MS workflows can help bring robustness, reproducibility, and throughput needed for routine bioanalysis.
November 9, 2026 at 1:02 PM
🚨 $CRL
On November 9, 2026, Charles River Laboratories International, Inc. issued a press release announcing that it has entered into definitive agreements to acquire Frontage Holdings Corporation’s bioanalysis and DMPK operations in Exton, Pennsylvania.
SEC Filing: CRL
Click to view the official SEC document.
www.sec.gov
November 9, 2026 at 11:14 AM
Charles River Agrees to Buy Frontage’s Exton Testing Businesses for $470 Million Plus Earnout

Jeff Dahl / CC BY-SA 2.0 Charles River Laboratories has agreed to acquire Frontage's bioanalysis and drug-metabolism testing businesses in Exton, Pennsylvania, for approximately $470 million in cash, plus…
Charles River Agrees to Buy Frontage’s Exton Testing Businesses for $470 Million Plus Earnout
Jeff Dahl / CC BY-SA 2.0 Charles River Laboratories has agreed to acquire Frontage's bioanalysis and drug-metabolism testing businesses in Exton, Pennsylvania, for approximately $470 million in cash, plus up to $75 million tied to future performance. The proposed acquisition, announced November 9, would expand Charles River's work supporting clinical drug development. The deal is not a purchase of all Frontage for Charles River to keep.
jbiznews.com
November 9, 2026 at 11:34 AM
Call For Papers | We are now accepting submissions for our new Article Collection Published within Bioanalysis, titled Bioanalysis of Antibody-Drug Conjugates.
Submission Deadline: 31st March 2027

spr.ly/63329BHQ4Dv
November 5, 2026 at 2:05 PM
Can LC-MS help solve bioanalysis challenges where ligand-binding assays fall short?

Read the article highlight and explore what standardized LC-MS can bring to bioanalysis: evosep.com/bioanalysis/#article-highlight
November 4, 2026 at 1:00 PM
Senior Associate Scientist - Bioanalysis

Regeneron - Tarrytown, US

Read the full job description and apply⤵️
jobrxiv.org/job/senior-a...

#ScienceJobs
November 2, 2026 at 4:31 PM
What if low-flow LC-MS no longer depended on expert operators?

By combining consistent Evotip sample loading and standardized separation, the Evosep approach is designed to reduce operator-to-operator variability and make low-flow LC-MS better suited to routine bioanalysis: evosep.com/bioanalysis
October 29, 2026 at 1:08 PM
Advancing the future of bioanalytical science? 🔬

Bioanalysis Advances welcomes research that bridges scientific discovery and real-world application.

🔎Discover the journal and submit your research: https://bit.ly/4yUAFMa
October 26, 2026 at 12:00 PM
Advancing the future of bioanalytical science? 🔬

Bioanalysis Advances welcomes research that bridges scientific discovery and real-world application.

🔎Discover the journal and submit your research: https://bit.ly/4BcPdZ4
October 26, 2026 at 12:00 PM
Advancing the future of bioanalytical science? 🔬

Bioanalysis Advances welcomes research that bridges scientific discovery and real-world application.

🔎Discover the journal and submit your research: https://bit.ly/4yUAFMa
October 26, 2026 at 12:00 AM
For years, bioanalytical laboratories have accepted a familiar trade-off: analytical-flow LC-MS for robustness, or low-flow LC-MS for sensitivity.

Today, workflow standardization is changing that equation.

Discover how: evosep.com/bioanalysis
October 21, 2026 at 1:15 PM
In this article, authors share how blood-based matrices are better suited than urine for detecting certain types of prohibited substances & tracking relevant biomarkers in the Athlete Biological Passport, as well as how matrix selection affects detection & analysis.
pubmed.ncbi.nlm.nih.gov/42764756/
October 9, 2026 at 8:42 PM
🚀 #SCIEXSummit2026 just keeps getting better.

Day 2 brought expert insights on bioanalysis, biopharma, GLP-1s, ADCs, HRMS, MetID, and the future of biotherapeutics. 🔬💊

A huge thank you to our speakers and all attendees. You made Day 2 unforgettable.🎉

🚨 One final day to go!
🔗 sciex.li/l8otz0ag
SCIEX Summit
Step into the frontier of innovation at the upcoming SCIEX summit 2026, where the brightest minds in analytical science will converge to ignite conversation, challenge ...
sciex.li
October 7, 2026 at 6:02 PM
🚀 Live now: Giovanna Aquino on bridging untargeted DMPK studies and targeted in vivo pharmacokinetics. 🔬

⏭️ Up next: Shane Needham on GLP-1 therapeutic quantitation, then Ryan Darling on ultrasensitive bioanalysis.

👀Catch the insights live, straight from the experts.
🔗 sciex.li/l8otz0ag
SCIEX Summit
Step into the frontier of innovation at the upcoming SCIEX summit 2026, where the brightest minds in analytical science will converge to ignite conversation, challenge ...
sciex.li
October 7, 2026 at 2:43 PM
(Associate) Principal Bioanalysis Scientist

AstraZeneca - Shanghai, China

Read the full job description and apply⤵️
jobrxiv.org/job/associat...

#ScienceJobs
October 6, 2026 at 3:31 PM
Bioanalysis and Biomarker Outsourcing Manager - Morristown, NJ Job educativ.net/jobs/job/66201...
October 1, 2026 at 5:18 AM
Bioanalysis and Biomarker Outsourcing Manager - Morristown, NJ Job educativ.net/jobs/job/66201...
October 1, 2026 at 4:51 AM
Bioanalysis and Biomarker Outsourcing Manager - Morristown, NJ Job educativ.net/jobs/job/66201...
October 1, 2026 at 4:03 AM